Click for best price
Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, Share 2023
A method for diagnosing gastrointestinal Stromal Tumor
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Stromal Tumor Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Stromal Tumor Molecular Diagnostics. This report contains market size and forecasts of Gastrointestinal Stromal Tumor Molecular Diagnostics in global, including the following market information:
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Gastrointestinal Stromal Tumor Molecular Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Gastrointestinal Stromal Tumor Molecular Diagnostics include Yin Feng Gene, KingMed, Geneis, Haplox, AmoyDX, Admera and GeneChem, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gastrointestinal Stromal Tumor Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Segment Percentages, by Type, 2022 (%)
PCR
FISH
DNA Sequencing
Gene Chip
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Segment Percentages, by Application, 2022 (%)
Clinical Diagnosis
Drug Screening
Research
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastrointestinal Stromal Tumor Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gastrointestinal Stromal Tumor Molecular Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Yin Feng Gene
KingMed
Geneis
Haplox
AmoyDX
Admera
GeneChem
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastrointestinal Stromal Tumor Molecular Diagnostics, market overview.
Chapter 2: Global Gastrointestinal Stromal Tumor Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Gastrointestinal Stromal Tumor Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastrointestinal Stromal Tumor Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Gastrointestinal Stromal Tumor Molecular Diagnostics Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Overall Market Size
2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size: 2022 VS 2030
2.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players in Global Market
3.2 Top Global Gastrointestinal Stromal Tumor Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Gastrointestinal Stromal Tumor Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gastrointestinal Stromal Tumor Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gastrointestinal Stromal Tumor Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Gastrointestinal Stromal Tumor Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Gastrointestinal Stromal Tumor Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 FISH
4.1.4 DNA Sequencing
4.1.5 Gene Chip
4.2 By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2022 & 2030
5.1.2 Clinical Diagnosis
5.1.3 Drug Screening
5.1.4 Research
5.2 By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2030
6.3.2 US Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.3.3 Canada Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.3.4 Mexico Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2030
6.4.2 Germany Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.4.3 France Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.4.4 U.K. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.4.5 Italy Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.4.6 Russia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.4.8 Benelux Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2030
6.5.2 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.5.3 Japan Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.5.4 South Korea Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.5.6 India Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2030
6.6.2 Brazil Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.6.3 Argentina Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2030
6.7.2 Turkey Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.7.3 Israel Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
6.7.5 UAE Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2018-2030
7 Gastrointestinal Stromal Tumor Molecular Diagnostics Companies Profiles
7.1 Yin Feng Gene
7.1.1 Yin Feng Gene Company Summary
7.1.2 Yin Feng Gene Business Overview
7.1.3 Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
7.1.4 Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Yin Feng Gene Key News & Latest Developments
7.2 KingMed
7.2.1 KingMed Company Summary
7.2.2 KingMed Business Overview
7.2.3 KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
7.2.4 KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 KingMed Key News & Latest Developments
7.3 Geneis
7.3.1 Geneis Company Summary
7.3.2 Geneis Business Overview
7.3.3 Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
7.3.4 Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Geneis Key News & Latest Developments
7.4 Haplox
7.4.1 Haplox Company Summary
7.4.2 Haplox Business Overview
7.4.3 Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
7.4.4 Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Haplox Key News & Latest Developments
7.5 AmoyDX
7.5.1 AmoyDX Company Summary
7.5.2 AmoyDX Business Overview
7.5.3 AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
7.5.4 AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 AmoyDX Key News & Latest Developments
7.6 Admera
7.6.1 Admera Company Summary
7.6.2 Admera Business Overview
7.6.3 Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
7.6.4 Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Admera Key News & Latest Developments
7.7 GeneChem
7.7.1 GeneChem Company Summary
7.7.2 GeneChem Business Overview
7.7.3 GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
7.7.4 GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 GeneChem Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers in Global Market
Table 3. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics in Global Market
Table 5. Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gastrointestinal Stromal Tumor Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Gastrointestinal Stromal Tumor Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastrointestinal Stromal Tumor Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. Yin Feng Gene Company Summary
Table 31. Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Product Offerings
Table 32. Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Yin Feng Gene Key News & Latest Developments
Table 34. KingMed Company Summary
Table 35. KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Product Offerings
Table 36. KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. KingMed Key News & Latest Developments
Table 38. Geneis Company Summary
Table 39. Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Product Offerings
Table 40. Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Geneis Key News & Latest Developments
Table 42. Haplox Company Summary
Table 43. Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Product Offerings
Table 44. Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Haplox Key News & Latest Developments
Table 46. AmoyDX Company Summary
Table 47. AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Product Offerings
Table 48. AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. AmoyDX Key News & Latest Developments
Table 50. Admera Company Summary
Table 51. Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Product Offerings
Table 52. Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Admera Key News & Latest Developments
Table 54. GeneChem Company Summary
Table 55. GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Product Offerings
Table 56. GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. GeneChem Key News & Latest Developments
List of Figures
Figure 1. Gastrointestinal Stromal Tumor Molecular Diagnostics Segment by Type in 2022
Figure 2. Gastrointestinal Stromal Tumor Molecular Diagnostics Segment by Application in 2022
Figure 3. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in 2022
Figure 8. By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
